University of California San Francisco

Chris E. Freise
Chris
Freise
MD, FACS

Professor of Surgery 
Chief, Division of Transplant Surgery

UCSF Diversity, Equity, and Inclusion Champion badge

Address

35 Medical Center Way, #001
San Francisco, CA 94143
United States

Email: [email protected]
Phone: 415-353-1898
Fax: 415-476-8709

    Biography

    Chris E. Freise, M.D. received his medical degree from the University of Minnesota where he also did his internship and residency in General Surgery. He later completed a  transplantation fellowship at UCSF.   

    He is a member of numerous professional organizations including The Transplantation Society, the International Pancreas and Islet Transplant Association, the Transplant Infectious Disease Society, the American Hepato-Pancreato-Billiary Association and the Society of University Surgeons. In addition, he recently served as the Medical Director for California Transplant Donor Network. He is also the Associate Counselor for UNOS Region 5, and a member of the UNOS Membership and Professional Standards Committee.

    Dr. Freise has authored more than eighty (80) in peer-reviewed publications and five (5) book chapters. He is an accomplished researcher and clinical educator. Dr. Freise is also a frequent invited lecturer to national and international and conferences in the field.         

    Education

    Institution Degree Dept or School End Date
    University of California Diversity, Equity, and Inclusion Champion Training 2019
    University of California, San Francisco Transplant Fellowship School of Medicine 1995
    University of California, San Francisco Post-Doc Fellow/Scholar School of Medicine 1991
    University of Minnesota M.D. School of Medicine 1986

    Board Certifications

    • American Board of Surgery, 1995

    Clinical Expertise

    Bile Duct Injuries
    Bile Duct Strictures
    Cholangiocarcinoma (Bile Duct Cancer)
    Choledochal Cyst Disease
    Dialysis Access
    Expanded Criteria Donor Kidney Transplantation
    Fulminant Hepatic Failure
    Hepatitis B
    Hepatitis C
    Hepatocellular Carcinoma (Liver Cancer)
    Intestinal Transplantation and Rehabilitation
    Kidney and LIver Transplantation in HIV Patients
    Kidney Auto-transplantation
    Kidney Transplantation
    Laparoscopic Donor Nephrectomy
    Laparoscopic Kidney and Liver Surgery
    Liver Transplantation
    Living Donor Kidney Transplantation
    Living Donor Liver Transplantation
    Pancreas Transplantation
    Pediatric Kidney Transplantation
    Pediatric Liver Transplantation
    Polycystic Kidney Disease
    Polycystic Liver Disease
    Portal Hypertension
    Surgical Shunts

    Grants and Funding

    • Living Donor Liver Transplant :Short & Long-Term Impact on Donors and Recipients | NIH | 2002-09-01 - 2015-08-31 | Role: Principal Investigator

    Research Narrative

    Dr. Friese's basic science research focuses on the delivery of immunosuppressive agents to organ allografts, ischemia reperfusion injury, and methods to improve organ function in deceased donors. His clinical research includes  a multicenter trial investigating donor and recipient outcomes following living donor liver transplantation.

    Research Interests

    Delivery of Immunosuppressive Agents to Organ Allografts

    Ischemia Reperfusion Injury

    Improvement Organ Function in Deceased Donors

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 125
    1. Catheter-directed therapy for DVT after pancreas transplantation.
      Mahanty HD, Posselt AM, Lipshutz GS, Schneider DB, Freise CE| | PubMed
    2. Laparoscopic nephrectomy, ex vivo partial nephrectomy followed by allograft renal transplantation.
      Whitson JM, Stackhouse GB, Freise CE, Meng MV, Stoller ML| | PubMed
    3. Improvement in survival associated with adult-to-adult living donor liver transplantation.
      Berg CL, Gillespie BW, Merion RM, Brown RS, Abecassis MM, Trotter JF, Fisher RA, Freise CE, Ghobrial RM, Shaked A, Fair JH, Everhart JE, A2ALL Study Group| | PubMed
    4. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
      Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL, A2ALL Study Group| | PubMed
    5. Glutamine donor pretreatment in rat kidney transplants with severe preservation reperfusion injury.
      Fuller TF, Rose F, Singleton KD, Linde Y, Hoff U, Freise CE, Dragun D, Niemann CU| | PubMed
    6. Predicting biliary complications in right lobe liver transplant recipients according to distance between donor's bile duct and corresponding hepatic artery.
      Yeh BM, Coakley FV, Westphalen AC, Joe BN, Freise CE, Qayyum A, McTaggart RA, Roberts JP| | PubMed
    7. Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation.
      Fuller TF, Hoff U, Rose F, Linde Y, Freise CE, Dragun D, Feng S| | PubMed
    8. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
      Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP| | PubMed
    9. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation.
      Fuller TF, Brennan TV, Feng S, Kang SM, Stock PG, Freise CE| | PubMed
    10. More than 500 consecutive laparoscopic donor nephrectomies without conversion or repeated surgery.
      Melcher ML, Carter JT, Posselt A, Duh QY, Stoller M, Freise CE, Kang SM| | PubMed